Pharmacy Times

JUNE 11, 2025

Image Credit: © Chinnapong - stock.adobe.com At the 2025 Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025, an encore presentation from the Pacific Coast Reproductive Society Annual Meeting will highlight findings from a retrospective analysis conducted by Walgreens Specialty Pharmacy.

Specialty Pharmacies

Pharmacy Times

JUNE 17, 2025

SHOW MORE This abstract will be presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 19 to 20, 2025. If a discrepancy is found, the pharmacy nurses will hold the shipment, and a clinical intervention will be communicated to the provider. AON Pharmacy's interventions saved $1.9

Mail-Order Pharmacies

Pharmacy Times

JUNE 8, 2025

At the American Society of Health-System Pharmacists (ASHP) Pharmacy Futures 2025 meeting, presenter Madison Wood, PharmD, CPh, BCPS, reviewed a groundbreaking model for integrating specialty pharmacists directly into neurology care teams.

Patient Care

Pharmacy Times

JULY 9, 2025

SHOW MORE Steroids hindered the shrinkage of tumors in patients with non-small cell lung cancer (NSCLC) receiving immune checkpoint inhibitor (ICI) therapy. The authors wrote that their findings could serve as a baseline for the steroids’ negative independent prognostic factor in patients with NSCLC undergoing ICI therapy.

Immunization

Pharmaceutical Technology

JUNE 23, 2025

June 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook HBM7020 activates immune system T cells to target and destroy B cells and plasma cells involved in many autoimmune diseases. We may still continue to send you service-related and other non-promotional communications. Credit: luchschenF /Shutterstock.

Communication

Drug Topics

JULY 18, 2025

Highlights include over 22 CE opportunities, 25 poster presentations, and the presentation of up to $40,000 in student scholarships. Meeting Preview: NPhA, SNPhA Annual Convention / Thananit - stock.adobe.com Attendees can expect an engaging and intimate experience, combining education with meaningful networking.

Health and Personal Care Stores

PharmTech

JUNE 12, 2025

Image Credit: © Tada Images - stock.adobe.com In a June 10, 2025 update, FDA posted seven updated Warning Letters, issued between the beginning of 2025 and the present, to its online database, which stores more than 3400 such letters dating back to 2020 (1). American Behavioral Research Institute Boca Raton, Fla. – Implications of RFK Jr.’s

FDA

Pharmacy Times

JUNE 20, 2025

She is deeply passionate about embracing the pillars of lifestyle medicine, self-care, effective communication, and inclusivity to create lasting positive health and wellness outcomes. CASE 2 Sunburn Treatment JJ, a 25-year-old, presents to the pharmacy seeking advice for a painful sunburn acquired during a recent vacation.

Compounding Pharmacies

Pharmacy Times

JUNE 18, 2025

They do present novel therapy options and novel combinations, but that doesn't necessarily mean that they're going to lead to the outcomes we're looking for—longer-term outcomes. Tim Mok, PharmD, BCOP, BCPS : Our panel was about leukemia and lymphoma, and there are exciting abstracts that came out, both at EHA and also at ASCO.

Chemotherapy

Drug Topics

JUNE 20, 2025

1 “In line with the goals of its Immunization Agenda 2030, WHO has identified a new list of 17 high-priority global endemic pathogens for vaccine research and development, of which skin pathogens account for at least 8, reinforcing the need for continued focus in this area.” Vaccines in dermatology-present and future: a review.

Vaccines

Pharmaceutical Technology

JUNE 20, 2025

Find out more This treatment involves obtaining immune cells from patients, modifying them in a laboratory setting then reintroducing them into patients’ bodies to destroy cancerous cells. We may still continue to send you service-related and other non-promotional communications. Don’t let policy changes catch you off guard.

Hospitals

Pharmaceutical Technology

JULY 1, 2025

A preliminary look at the data from Capstan has revealed strong B-cell depletion – the aim of the treatment is to achieve an ‘immune reset’ by repopulation of healthy B cells. We may still continue to send you service-related and other non-promotional communications. higher at $185.62 on 30 June, the day the announcement was made.

Packaging

Pharmacy Times

JULY 29, 2025

Geison’s The Private Science of Louis Pasteur provides a historical framework for examining long-standing patterns in scientific communication, particularly the divergence between experimental practice and published narrative.

Department of Veterans Affairs

Drug Topics

JUNE 7, 2025

3 “There is concern that there are going to be growing numbers of larger communities that are unvaccinated or [are] below the threshold of vaccination needed for herd immunity, and that’s going to potentially leave people vulnerable to ongoing outbreaks and one of the reasons why it’s been difficult to get this current outbreak under control."

Vaccines

Drug Topics

JUNE 11, 2025

1 “Psoriasis is a chronic disease in which the immune system becomes overactive, causing skin cells to multiply too quickly,” wrote the National Institute of Arthritis and Musculoskeletal and Skin Diseases. Significantly linked with psoriasis, PsA is a chronic skin and nail disease 3 that impacts up to 30% of patients with psoriasis.

Immunization

Drug Topics

JULY 10, 2025

The integration of medicinal plant extracts with advanced drug delivery presents a significant opportunity for reducing UV-induced skin damage, according to a study published in the International Journal of Molecular Sciences. They play an important role in cell communication and regeneration.

Compounding

Drug Topics

JULY 11, 2025

1 “The treatment and prevention of allergic-related skin diseases still present challenges. It reveals that although incidence and prevalence rates vary across regions and countries, the overall trends are generally consistent with previous research,” they concluded.

Vaccines

Pharmaceutical Technology

JUNE 12, 2025

By GlobalData Learn more about Strategic Intelligence By covering a wide range of targets on malignant B cells, the therapy aims to enhance safety and efficacy while minimising the potential of tumour cells for developing immune-resistance mechanisms such as antigen escape. Give your business an edge with our leading industry insights.

Communication

Pharmaceutical Technology

JUNE 25, 2025

RFK Jr has flip-flopped between endorsing and shunning the MMR vaccine , a shot that is proven to provide strong immunity against the disease. A clue to its outlook will likely present itself in the next ACIP meeting, though the long-term future of vaccines in the US with RFK Jr at the HHS helm remains unclear.

Vaccines

Pharmaceutical Technology

JUNE 16, 2025

At the 2025 Congress of the European Hematology Association (EHA 2025), held from 12 June 12 to 15 June in Milan, Italy, preliminary dose-escalation and optimisation results from the global, multicentre, open-label, single-arm Phase I/II SYRUS clinical trial (NCT06137118) were presented on the second day.

Labelling

European Pharmaceutical Review

MARCH 6, 2023

Investigators assessed whether administering a temperature-stable vaccine containing both ID93 and GLA-SE in a single vial would be as effective at inducing an immune response as a regimen in which non-thermostable ID93 and liquid GLA-SE are held in two vials and combined prior to injection. However, Sagawa et al. However, Sagawa et al.

Immunization

Hospital Pharmacy Europe

OCTOBER 25, 2024

A study has identified subtle changes in how immune cells respond to different severe febrile illnesses in children, which could lead to improved treatments. In the clinic currently, our treatments for dysfunctional immunity are poor and not targeted to individual children.

Immunization

Board Vitals - Pharmacist

OCTOBER 23, 2024

A 6-year-old boy is evaluated for a cough that has been present for the last 6 weeks. His mother reports that he has not had any immunizations since 4 months of age. He was seen by his pediatrician 5 weeks ago for low grade fever, cough and runny nose. His vital signs are normal and physical examination is unremarkable.

Medical Schools

Pharmaceutical Technology

JANUARY 10, 2023

These therapies work by reprogramming the immune system, preventing it from attacking and eradicating insulin-producing cells in the pancreas. Although T1D can present in younger children and older adults, the FDA notes that the most common age of onset is between ages four and 14. Equity in early-stage testing.

Immunization

Pharma Marketing Network

DECEMBER 21, 2020

To fully realize the potential of these transformative technologies, there needs to be a deep understanding of the communication needs – both educational and promotional – that healthcare systems will face with their introduction. Here are 5 considerations when developing a communications strategy for a novel genetic medicine. #1.

Communication

The Checkup by Singlecare

NOVEMBER 9, 2023

These foods will not necessarily cure sinus infections but complement other therapies by providing benefits such as solid immunity and reduced inflammation. Research has shown that getting enough rest is essential for your immune system to mount a defense against infections and inflammations.

Immunization

Pharmaceutical Technology

DECEMBER 7, 2022

At CTAD, experts presented data from the Clarity AD clinical trial , where lecanemab met the primary endpoint—a mean change in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) scale—by reducing clinical decline by 27% compared to placebo , at 18 months of treatment. Please check your email to download the Report.

Communication

Pharmaceutical Technology

DECEMBER 7, 2022

At CTAD, experts presented data from the Clarity AD clinical trial , where lecanemab met the primary endpoint—a mean change in the Clinical Dementia Rating-Sum of Boxes (CDR-SB) scale—by reducing clinical decline by 27% compared to placebo , at 18 months of treatment. Please check your email to download the Report.

Communication

The Thyroid Pharmacist

AUGUST 4, 2023

In fact, it’s present in up to 55 percent of the European population, is naturally occurring, and often has no negative health consequences – unless expressed. [1] The word mutation makes it sound like there’s something wrong with the person, while variation is more empowering – and in my opinion, also more accurate.

Insurance

The Thyroid Pharmacist

APRIL 23, 2023

I believe that adrenal, immune, and thyroid issues develop as an adaptive mechanism to protect us in times of perceived danger. Pleasurable Activities – Allocating time for self-care is a way of making sure we have the energy and focus to be present in all of the ways that matter for our loved ones.

Communication

The Thyroid Pharmacist

MARCH 24, 2023

Certain medical conditions that are associated with fatigue , inflammation, and blood sugar imbalances — such as hypothyroidism — often present with symptoms of brain fog. [1] When chronic inflammation is present, oxidative stress is present much of the time, too. When your gut is inflamed, most likely your brain is, too.

Compounding

Pharmaceutical Technology

MAY 4, 2023

Cases of nontuberculous mycobacteria (NTM) infections are growing globally, presenting numerous challenges for healthcare facilities in keeping vulnerable patients safe. While Pseudomonas and Legionella present considerable challenges, they are easier to detect and treat than NTM. Please check your email to download the Brochure.

Hospitals

PQA

DECEMBER 13, 2024

However, several aspects of OAMs present distinct hurdles to measuring adherence or persistence to therapy in a standardized and valid way. This fall, we launched a pilot to evaluate the effectiveness of pharmacies in improving adult immunization rates through VBAs with payers. Results from this two-year project will be shared in 2026.

Communication

Pharmaceutical Technology

APRIL 17, 2023

The Fc region interacts with the cell surface receptors to cause the protective immune response. The company’s past and present collaborators include Abbvie, Novartis and Seagen. The company has previously co-developed drugs that include bispecific T-cell engagers and immune checkpoint modulators.

Immunization

Pharmaceutical Technology

APRIL 4, 2023

On 4 April, the Danish immune-oncology company Adcendo announced the extension of a series A financing round to €82 million ($89.6 Adcendo’s ADCs treat cancer by inhibiting uPARAP, which is present on several mesynchymal cancer cells such as fibroblasts, osteoblasts and chondrocytes. Please check your email to download the Report.

Immunization

Pharmaceutical Technology

MAY 17, 2023

Intercept plans to present the first data at the 2023 European Association for the Study of the Liver (EASL) Congress, which will take place in Vienna, Austria, June 21–24. Primary biliary cholangitis is a rare autoimmune disease where small bile ducts are injured by the patient’s own immune system. billion in 2029.

FDA

Pharmaceutical Technology

APRIL 20, 2023

According to the company’s January 2023 corporate presentation, there are 280,000 toddlers and 390,000 children living with peanut allergy in the US. The company’s patch technology delivers trace amounts of allergens to build an immune response. Please check your email to download the Report.

FDA